Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1468
| Despition | MEIS3 Human Recombinant |
| SIZE | 5 µg |
| Purity | > 85.0% (SDS-PAGE) |
| Form | Sterile Filtered colorless solution. |
| Storage | Store at 4°C for 2-4 weeks. |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1839 | Human Ornithine Aminotransferase Protein (AC1839) | 5 µg | inquiry |
| ACPP-1080 | GABA B Receptor 2 Blocking Peptide (AC1080) | 250 µg | inquiry |
| ACPP-1002 | Recombinant Human CD147 Protein (Fc Tag) (AC1002) | 50 µg | inquiry |
| ACPP-1300 | GTP cyclohydrolase 1 Blocking Peptide (AC1300) | 250 µg | inquiry |
| ACPP-1408 | Human SH3GL3 Protein (AC1408) | 5 µg | inquiry |
| ACPP-1017 | Recombinant Human FGF19 Protein (AC1017) | 50 µg | inquiry |
| ACPP-1362 | MERTK Blocking Peptide (AC1362) | 250 µg | inquiry |
| ACPP-1641 | Adenylate cyclase 1 Blocking Peptide (AC1641) | 250 µg | inquiry |
| ACPP-1455 | Human PIN1 Protein (AC1455) | 5 µg | inquiry |
| ACPP-1828 | Human EPHA2 Protein (AC1828) | 2 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.